iECURE reports positive results from gene therapy trial for rare disorder

May 18, 2026 8:02 AM

iECURE Inc. announced preliminary results from its ongoing clinical trial of ECUR-506, an experimental gene therapy for neonatal-onset ornithine transcarbamylase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found